Literature DB >> 23500187

Role of maternal viremia and placental infection in hepatitis B virus intrauterine transmission.

Yong Chen1, Lijuan Wang, Yunfang Xu, Xingxiang Liu, Shouzhong Li, Qiang Qian, Bin Hu, Aijun Zhou, Tianyan Chen, Yingren Zhao.   

Abstract

The mechanism of intrauterine hepatitis B virus infection has not been established. In this study, venous blood, cord blood, and placental tissues from 171 chronic hepatitis B virus infected pregnant women were tested for hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA. We found that residence, mode of delivery, age, and number of gestational weeks of pregnant women were not correlated with intrauterine hepatitis B virus infection, while neonates of mothers who were hepatitis B s antigen positive and hepatitis B e antigen positive (P < 0.01) or who had high hepatitis B virus DNA levels (≥10(6) copies/ml) were more likely to get an intrauterine infection (P < 0.01). The hepatitis B virus infection rate in placental cell layers gradiently decreased from the mother's side to the fetus's side of the placenta, but the odds ratio value of correlation between placental hepatitis B virus infection and intrauterine infection gradiently increased. The way of intrauterine hepatitis B virus infection may be through a layer-layer transmission pathway, although the possibility of placental leakage cannot be excluded.
Copyright © 2013 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500187     DOI: 10.1016/j.micinf.2013.02.008

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  8 in total

1.  Solely HBsAg intrauterine exposure accelerates HBV clearance by promoting HBs-specific immune response in the mouse pups.

Authors:  Jing Ning; Jianwen Wang; Huiling Zheng; Siwen Peng; Tianhao Mao; Lu Wang; Guangxin Yu; Jia Liu; Shuang Liu; Ting Zhang; Shigang Ding; Fengmin Lu; Xiangmei Chen
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

Review 2.  Caesarean section to prevent transmission of hepatitis B: a meta-analysis.

Authors:  Matthew S Chang; Sravanya Gavini; Priscila C Andrade; Julia McNabb-Baltar
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09

3.  An "immune barrier" is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother.

Authors:  Jinfeng Liu; Yuling Feng; Jing Wang; Xuelan Li; Chunmei Lei; Dongfang Jin; Weihong Feng; Yuan Yang; Yingli He; Yuanyuan Li; Dan Du; Xuebin Zhang; Li Jin; Taotao Yan; Tianyan Chen; Yingren Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis.

Authors:  Marianna G Mavilia; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2017-06-07

5.  Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women.

Authors:  Erry Gumilar Dachlan; Cahyanti Nugraheni; Alphania Rahniayu; Muhammad Ilham Aldika Akbar
Journal:  J Family Reprod Health       Date:  2020-06

Review 6.  Intrauterine Infection and Mother-to-Child Transmission of Hepatitis B Virus: Route and Molecular Mechanism.

Authors:  Xianlei Zhao; Xiaoxia Bai; Yongmei Xi
Journal:  Infect Drug Resist       Date:  2022-04-12       Impact factor: 4.177

7.  Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.

Authors:  Qiuju Sheng; Yang Ding; Baijun Li; Chao Han; Yanwei Li; Chong Zhang; Han Bai; Jingyan Wang; Lianrong Zhao; Tingting Xia; Ziying An; Mingxiang Zhang; Xiaoguang Dou
Journal:  Int J Med Sci       Date:  2018-05-22       Impact factor: 3.738

Review 8.  Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B.

Authors:  Yoon Seok Lee; Soo Min Bang; Young-Sun Lee
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.